This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTX at https://www.zacks.com/ap/CYTX Keywords: Cytori Therapeutics, …
The Company's common stock will continue to trade under the symbol "CYTX" following the transfer of its listing to The NASDAQ Capital Market tier. The continued listing of the Company's common stock on The NASDAQ Capital Market …
SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ:CYTX), a late stage cell therapy company developing ... M.D., Senior Vice President of Clinical Affairs, a non-qualified stock option to purchase an aggregate of …
For more information, get Portfolio Grader’s complete analysis of CCLP stock. Louis Navellier ... from InvestorPlace Media, http://investorplace.com/2016/05/5-stocks-with-poor-earnings-revisions-fve-rlgt-cdi-cytx-cclp/.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTX at https://www.zacks.com/ap/CYTX Keywords: Cytori Therapeutics, …